Published in FEMS Microbiol Lett on June 01, 1992
Bacteriophage control of bacterial virulence. Infect Immun (2002) 2.97
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis (2000) 2.51
Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun (1996) 2.13
Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol (1999) 1.75
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) (2012) 1.10
Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun (1998) 1.06
Shiga toxin-producing Escherichia coli-associated kidney failure in a 40-year-old patient and late diagnosis by novel bacteriologic and toxin detection methods. J Clin Microbiol (2003) 0.83
The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7. PLoS One (2013) 0.77
Culture negative cytotoxin positive stools in community acquired diarrhoea. Gut (1993) 0.75
The EspF N-Terminal of Enterohemorrhagic Escherichia coli O157:H7 EDL933w Imparts Stronger Toxicity Effects on HT-29 Cells than the C-Terminal. Front Cell Infect Microbiol (2017) 0.75
Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol (1987) 4.35
Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet (1987) 3.79
Cloning of genes determining the production of vero cytotoxin by Escherichia coli. J Gen Microbiol (1985) 3.60
Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child (1990) 3.51
Lymphocytic gastritis--relationship to Campylobacter pylori infection. J Pathol (1988) 2.88
Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet (1991) 2.80
Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans. Infect Immun (1982) 2.62
New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans. Infect Immun (1982) 2.52
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet (1976) 2.31
Vero cytotoxin-producing strains of Escherichia coli. J Med Microbiol (1988) 2.29
Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157. J Infect Dis (1992) 2.23
Candida endocarditis treated with 5-fluorocytosine. Br Med J (1971) 2.20
Limitations of laser treatment for malignant dysphagia. Br J Surg (1992) 2.08
Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome. J Clin Microbiol (1989) 2.08
HEp-2 adhesion and the expression of a 94 kDa outer-membrane protein by strains of Escherichia coli belonging to enteropathogenic serogroups. J Gen Microbiol (1988) 1.99
Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet (1974) 1.97
Should colonoscopy be the first investigation for colonic disease? Br Med J (Clin Res Ed) (1988) 1.78
Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract (1996) 1.78
Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage. Lancet (1983) 1.73
Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol (1984) 1.68
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK. Epidemiol Infect (1988) 1.66
Serotype-related enterotoxigenicity in Escherichia coli O6.H16 and O148.H28. J Hyg (Lond) (1977) 1.58
Hybridization of strains of Escherichia coli O157 with probes derived from the eaeA gene of enteropathogenic E. coli and the eaeA homolog from a Vero cytotoxin-producing strain of E. coli O157. J Clin Microbiol (1994) 1.57
Vero cytotoxin production and presence of VT genes in Escherichia coli strains of animal origin. J Gen Microbiol (1988) 1.57
Measurement of anal cushions in idiopathic faecal incontinence. Br J Surg (2009) 1.54
Expression of plasmids coding for colonization factor antigen II (CFA/II) and enterotoxin production in Escherichia coli. J Gen Microbiol (1983) 1.53
Phage-typing of Vero-cytotoxin (VT) producing Escherichia coli O157 isolated in the United Kingdom. Epidemiol Infect (1989) 1.50
Comparison of an HEp-2 tissue culture test with the Serény test for detection of enteroinvasiveness in Shigella spp. and Escherichia coli. J Clin Microbiol (1981) 1.46
Plasmids that code for production of colonization factor antigen II and enterotoxin production in strains of Escherichia coli. Infect Immun (1983) 1.46
Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157. Lancet (1984) 1.46
Comparison of Vero-cytotoxin-encoding phages from Escherichia coli of human and bovine origin. J Gen Microbiol (1989) 1.45
Measurement of anal cushions in continent women. Colorectal Dis (2010) 1.41
Fatal intrahepatic cholestasis associated with triazolam. Postgrad Med J (1981) 1.39
Plasmids coding for heat-labile enterotoxin production isolated from Escherichia coli O78: comparison of properties. J Bacteriol (1980) 1.37
Production of heat-labile or heat-stable enterotoxins by strains of Escherichia coli belonging to serogroups O44, O114, and O128. Infect Immun (1981) 1.35
Spectrum of antibiotic-associated diarrhoea. Gut (1981) 1.34
Acid-base and metabolic disturbances in fulminant hepatic failure. Gut (1975) 1.34
Escherichia coli O157:H7 associated with human infections in the United Kingdom. Lancet (1983) 1.32
Enterotoxigenic Escherichia coli causing infantile enteritis in Britain. Lancet (1977) 1.31
ACP Broadsheet 135: January 1993. Isolation and identification methods for Escherichia coli O157 and other Vero cytotoxin producing strains. J Clin Pathol (1993) 1.30
Properties of Vero cytotoxin-producing Escherichia coli of human and animal origin belonging to serotypes other than O157:H7. Epidemiol Infect (1989) 1.23
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
Isolates of Escherichia coli O44:H18 of diverse origin are enteroaggregative. J Infect Dis (1994) 1.21
Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol (1987) 1.21
Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors. Epidemiol Infect (1991) 1.20
Transposition of ampicillin resistance to an enterotoxin plasmid in an Escherichia coli strain of human origin. J Bacteriol (1979) 1.20
Primary and secondary malignant disease of the liver and fulminant hepatic failure. J Clin Gastroenterol (1990) 1.19
Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C. J Clin Pathol (2001) 1.15
Metabolic changes in active chronic hepatitis. Clin Sci (1972) 1.11
Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? Aliment Pharmacol Ther (2004) 1.09
Attaching and effacing lesions in vivo and adhesion to tissue culture cells of Vero-cytotoxin-producing Escherichia coli belonging to serogroups O5 and O103. J Gen Microbiol (1990) 1.09
Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol (1989) 1.08
The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res (1992) 1.08
Detection and differentiation of the gene for toxin co-regulated pili (tcpA) in Vibrio cholerae non-O1 using the polymerase chain reaction. FEMS Microbiol Lett (1995) 1.07
Methionine and cysteamine in paracetamol (acetaminophen) overdose, prospective controlled trial of early therapy. J Int Med Res (1981) 1.05
Letter: Serotyping of enteropathogenic Escherichia coli. Lancet (1975) 1.04
Magnetic motor evoked potential monitoring in the rat. J Neurosurg (1999) 1.04
Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance? J Intern Med (1993) 1.03
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol (1992) 1.03
Primary biliary cirrhosis after long-term practolol administration. Br Med J (1978) 1.02
Properties of adherence factor plasmids of enteropathogenic Escherichia coli and the effect of host strain on expression of adherence to HEp-2 cells. J Gen Microbiol (1989) 1.02
Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. Gut (1987) 1.02
Serum killing of meningococci and several other gram-negative bacterial species is not decreased by incubating them with cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog (1989) 1.01
Acute gluten challenge in treated adult coeliac disease: a morphometric and enzymatic study. Gut (1985) 1.00
Outbreak of infantile enteritis caused by enterotoxigenic Escherichia coli O6.H16. J Clin Pathol (1978) 1.00
Properties of wild-type strains of enterotoxigenic Escherichia coli which produce colonization factor antigen II, and belong to serogroups other than O6. J Gen Microbiol (1985) 0.99
The biological sulphation of L-tyrosyl peptides. Biochem J (1966) 0.98
Cytotoxic enteropathogenic Escherichia coli. Lancet (1980) 0.98
Morbidity and mortality after closure of loop ileostomy. Colorectal Dis (2008) 0.97
Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis. Br Med J (Clin Res Ed) (1985) 0.97
Is a persistent adenovirus infection involved in coeliac disease? Gut (1989) 0.97
Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther (2003) 0.97
Do gastric and oesophageal varices bleed at different portal pressures and is TIPS an effective treatment? Liver (2000) 0.95
Catabolite repression of the adhesion of Vero cytotoxin-producing Escherichia coli of serogroups O157 and O111. Microb Pathog (1995) 0.95
Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology (1997) 0.94
A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka. Epidemiol Infect (1993) 0.94
Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J (Clin Res Ed) (1982) 0.94
Lasting paraplegia caused by loss of lumbar spinal cord interneurons in rats: no direct correlation with motor neuron loss. J Neurosurg (2000) 0.93
Effect of methionine loading and endogenous hypermethioninaemia on blood mercaptans in man. Clin Chim Acta (1988) 0.92
The occurrence of plasmids carrying genes for both enterotoxin production and drug resistance in Escherichia coli of human origin. J Hyg (Lond) (1979) 0.91
The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum (1990) 0.90
A pilot study of fluticasone propionate in untreated coeliac disease. Gut (1991) 0.90
The impact of an endoscopic laser service on gastroenterological practice. Q J Med (1989) 0.90
Constrictive pericarditis and intestinal haemorrhage due to Whipple's disease. Postgrad Med J (1983) 0.90
Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol (1989) 0.90
Morphometric studies in duodenal biopsies from patients with coeliac disease: the effect of the steroid fluticasone propionate. Aliment Pharmacol Ther (1991) 0.90
Examination of strains belonging to enteropathogenic Escherichia coli serogroups for genes encoding EPEC adherence factor and Vero cytotoxins. J Med Microbiol (1990) 0.90
Plasmapheresis in acute liver failure. Int J Artif Organs (1986) 0.89
Acquisition and maintenance of enterotoxin plasmids in wild-type strains of Escherichia coli. J Gen Microbiol (1983) 0.89
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM (2008) 0.89
Fulminant hepatic failure due to Budd Chiari syndrome. Lancet (1980) 0.88
Effects of rolipram on adult rat oligodendrocytes and functional recovery after contusive cervical spinal cord injury. Neuroscience (2009) 0.88
Adhesion to and invasion of human colon carcinoma Caco-2 cells by Aeromonas strains. J Med Microbiol (1994) 0.87
Multiple biochemical effects in the pathogenesis of alcoholic fatty liver. Eur J Clin Invest (1997) 0.87
High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Hepatology (1996) 0.87
The flexible sigmoidoscope. Lancet (1984) 0.87
Enterotoxigenic Escherichia coli causing diarrhoea in travellers returning to the United Kingdom. Br Med J (1979) 0.87
A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology (1989) 0.86